Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2024 07:58 ET | Source: CAMP4 Therapeutics

CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders

CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle D
May 25, 2021 08:50 ET | Source: CMI

Global Urea Cycle Disorders Treatment Market to Surpass US$ 1,510.2 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE, May 25, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global urea cycle disorders treatment market is estimated to be valued at US$ 1,188.9 million in 2020 and is...

Search Results